- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-29-0054853

Cadilab Pharma Private Limited
About Cadilab Pharma Private Limited
Data last updated:
Cadilab Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 May 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2022PTC397933. Its GSTIN is 09AAKCC2931R1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Anil Dubey and Ajay Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 488 Chander Lok Street No. 3 Mandoli Road Shahdara, Delhi, India – 110093.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.16 Lakh, a decline of 78% compared to the previous year. For the same year it recorded a net loss of ₹15.14 Lakh (net margin -124.5%) and EBITDA of -₹14.56 Lakh (EBITDA margin -119.8%).
Cadilab Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0054853).
Company details
Recognitions & Rankings of Cadilab Pharma
Contact details
Cadilab Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address488 Chander Lok Street No. 3 Mandoli Road Shahdara, Delhi, India – 110093
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cadilab Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cadilab Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cadilab Pharma Private Limited, buy the company report.
Financials of Cadilab Pharma Private Limited
FY 2025 filings availableCadilab Pharma Private Limited reported revenue of ₹12.16 Lakh (down 78% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 78% in the latest year. EBITDA rose 38% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹14.56 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹15.14 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -119.8% | ||
| Net Profit Margin | -124.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Cadilab Pharma Private Limited, buy the company report.
Board of directors of Cadilab Pharma Private Limited
Cadilab Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Dubey | Director | 07 May 2022 | 4 Years 5 Months | Current |
| Ajay Tyagi | Director | 07 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Cadilab Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lamboria Healthcare Private Limited | ₹12.32 Lakh (FY 2024) | -43.0% | Samastipur, Bihar, India | |||
| Moseley Pharmaceuticals Private Limited | ₹12.2 Lakh (FY 2025) | -59.0% | Lucknow, Uttar Pradesh, India | |||
| Cadilab Pharma Private Limitedthis company | ₹12.16 Lakh (FY 2025) | -₹15.14 Lakh | -124.5% | -78.0% | Delhi, India | |
| Tibard Pharma Private Limited (OPC) | ₹12.15 Lakh (FY 2018) | -23.0% | Fatehpur, Uttar Pradesh, India |
To see the full peer comparison of Cadilab Pharma Private Limited, buy the company report.
Auditor
Cadilab Pharma Private Limited is audited by A P KUMAR & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A P KUMAR & ASSOCIATES | FY 2023 | 003028N |
Shareholding
The shareholding of Cadilab Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Cadilab Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cadilab Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cadilab Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cadilab Pharma Private Limited has 1 active EPFO establishment as of Apr 10, 2024.
GST
Cadilab Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCC2931R1Z1 | Uttar Pradesh | Active | 02 Jun 2022 |
To see the full GST registrations and return filing status of Cadilab Pharma Private Limited, buy the company report.
Recent activity
Cadilab Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Ajay Tyagi was appointed as Director on 07 May 2022.
Frequently asked questions
Cadilab Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 May 2022 (4+ years old) and is registered under CIN U24230DL2022PTC397933.
Cadilab Pharma has 2 current directors:
- Anil Dubey - Director
- Ajay Tyagi - Director
The latest financial statements of Cadilab Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Cadilab Pharma is 09AAKCC2931R1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Cadilab Pharma is U24230DL2022PTC397933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cadilab Pharma was incorporated on 07 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cadilab Pharma by revenue are Lamboria Healthcare Private Limited, Moseley Pharmaceuticals Private Limited, Tibard Pharma Private Limited (OPC), all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ajay Tyagi was appointed as Director on 07 May 2022. Anil Dubey was appointed as Director on 07 May 2022.
Yes, Cadilab Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0054853).
The registered office of Cadilab Pharma is at 488 Chander Lok Street No. 3 Mandoli Road Shahdara, Delhi, India – 110093.
Cadilab Pharma operates in the pharma industry, in the drug formulation and development segment.